We report here on a novel stromal cell line, AGM-S3, derived from the aorta-gonad-mesonephros (AGM) region of a 10.5 days postcoitum (dpc) mouse embryo. The AGM-S3 cells promoted production of hematopoietic progenitors and day-12 spleen colony-forming cells from Linc-Kit+Sca-1+ murine primitive hematopoietic cells. They also supported for 6 weeks generation of human multipotential progenitors from cord blood CD34+CD38 primitive hematopoietic cells. Human long-term repopulating hematopoietic stem cells (LTR-HSC) with the potential to reconstitute hematopoiesis in NOD/SCID mice were maintained on AGM-S3 cells for at least 4 weeks. Flow cytometric analysis showed that CD13, vascular cellular adhesion molecule-1, and Sca-1 were expressed on AGM-S3 cells. Because stem cell factor, interleukin-6 (IL-6), and oncostatin M, but not IL-3, IL-11, leukemia- inhibitory factor, granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, thrombopoietin, and Flk2 ligand were detected in reverse transcription-polymerase chain reaction analysis of AGM-S3 cells, the cells seem to express species-cross reactive molecule(s) other than the cytokines examined and which act on primitive hematopoietic progenitor/stem cells. This cell line is expected to elucidate molecular mechanisms regulating early hematopoiesis and pave the way for developing strategies for expansion of human transplantable HSC.

© 1998 by The American Society of Hematology.

MUCH ATTENTION has been directed to regulatory mechanisms governing the proliferation, self-renewal, and differentiation of primitive hematopoietic stem and progenitor cells. Knowledge of such mechanisms will facilitate ex vivo expansion of human hematopoietic stem cells for transplantation and for gene therapy. Although cytokines that act on primitive hematopoietic cells have been identified,1 attempts to expand transplantable hematopoietic stem cells by defined cytokines have had limited success.2-4 It is widely accepted that the microenvironment plays an important role in hematopoiesis in vivo5 and that stromal cells are principal components of the microenvironment. Indeed, several cloned stromal cell lines can promote the survival, proliferation, and differentiation of hematopoietic cells in vitro.6-9 

In the developing mouse embryo, hematopoietic cells first appear in the yolk sac (YS) at 7.5 days postcoitum (dpc),10 but recent studies have shown that definitive hematopoiesis might originate in an intraembryonic site. Dissections of 8 to 9 dpc embryos have localized multipotent progenitor activity to the para-aortic splanchnopleural mesoderm (P-Sp).11 It has been shown that spleen colony-forming units (CFU-S) appear simultaneously in YS and aorta-gonad-mesonephros (AGM) region at late 9 dpc.12 The number and frequency of CFU-S in the AGM region greatly exceed those in the YS, increase dramatically at late 10 dpc, and then decrease at 11 dpc before a concomitant increase in the fetal liver (FL). It has been also demonstrated that, using conditioned newborn or embryonic mice as hematopoietic transplant recipients, long-term repopulating hematopoietic stem cells (LTR-HSC) can be detected as early as 9 dpc in YS and P-Sp.13 However, when conditioned adult mice are used as the recipients, LTR-HSC are first noted in the AGM region at 10 dpc, before such activity being observed in YS and FL, and expand in 11 dpc AGM region,14 15 suggesting that the AGM region at 10 to 11 dpc provides a microenvironment suitable for the development of LTR-HSC. These observations prompted us to establish stromal cell lines from the AGM region at 10 to 11 dpc, which would support ex vivo expansion of HSC.

We obtained a stromal cell line, AGM-S3, derived from the AGM region of 10.5 dpc mouse embryo. When cocultured with the stromal cells, hematopoietic cells, especially primitive hematopoietic progenitor/stem cells in adult mouse bone marrow and human cord blood, significantly proliferated without additional cytokines. This cell line can now be used to elucidate the molecular mechanisms regulating early hematopoiesis and provide strategies for the manipulation of primitive hematopoietic progenitor/stem cells.

Mice and tissues.

C3H/HeN and C57BL/6 mice, 8 to 10 weeks old, were purchased from Shizuoka Animal Farm (Shizuoka, Japan) and kept under specific pathogen-free conditions. One or two female C3H/HeN mice were caged with a male for 2 hours late in the afternoon and then examined for vaginal plugs. The appearance of the vaginal plug was designated as day 0 of gestation. On day 10.5 of gestation, pregnant mice were anesthetized by ether and then killed by cervical dislocation; from the embryos we dissected the region surrounding aorta, genital ridge, and mesonephros using a dissecting microscope and phosphate-buffered saline (PBS; Nissui, Tokyo, Japan). Eight-week-old male C57BL/6 mice were used for the assay of hematopoietic progenitors and CFU-S.

Cell preparation.

Mouse bone marrow cells (BMC) were flushed from femurs and tibiae into a-medium (Flow Laboratories, Rockville, MD). Human umbilical cord blood cells (CBC), collected according to institutional guidance, were obtained during normal full-term vaginal deliveries. Mononuclear cells (MNC) were separated by Ficoll-Hypaque density gradient centrifugation after depletion of phagocytes with Silica (IBL, Fujioka, Japan). CD34+ cells were purified from MNC by using Dynabeads M-450 CD34 and DETACHaBEAD CD34 (Dynal, Oslo, Norway).16 Eighty-five percent to 95% of the cells separated were CD34 positive by flow cytometric analysis. MS-5 cells were kindly provided by Dr Kazuhiro J. Mori (Niigata University, Niigata, Japan).

Cytokines.

Recombinant human (h) and mouse (m) stem cell factor (SCF) and mouse interleukin-3 (IL-3) were kindly provided by Amgen (Thousand Oaks, CA). Recombinant human IL-3, IL-6, granulocyte colony-stimulating factor (G-CSF), erythropoietin (EPO), and thrombopoietin (TPO) were a generous gift from Kirin Brewery Co Ltd (Tokyo, Japan). All the cytokines were pure recombinant molecules and were used at concentrations that induced optimal response in methylcellulose culture of human and mouse hematopoietic cells.

Establishment of stromal cell lines.

AGM tissues were removed from 10.5 dpc embryos of C3H/HeN mice, dissected to some pieces whose length was approximately 0.3 mm, and cultured in 24-well plates (#143982; Nunc, Naperville, IL) overnight with a drop of α-medium containing 10% fetal bovine serum (FBS; Hyclone Laboratories, Logan, UT) at 37°C in a humidified atmosphere flushed with 5% CO2 in air, and 1 mL of culture medium was added to the well the next day. The adherent cells appeared around the tissues 1 week later, and the AGM tissues were then removed. After 1 additional week of incubation, the adherent cells were harvested from the well using 0.05% trypsin containing 0.53 mmol EDTA (GIBCO BPL, Grand Island, NY) and were plated in 6-well plates (#152795; Nunc). After 2 weeks of incubation, the cultured cells were irradiated with 900-rad γ-ray to deplete hematopoietic cells. The medium was replaced with fresh culture medium once weekly. Adherent cells were harvested 2 weeks later using trypsin and 50 to 100 cells were seeded into 24-well plates. After 3 weeks of incubation, cells expanded in a well were harvested and used for cell cloning by the limiting dilution technique (0.3 cells/well).17 When proliferating cells were present in each well, they were individually transferred to 25-cm2flasks (#163371; Nunc) containing the culture medium described above. Seventeen cloned cell lines were consequently established. Fourteen of them showed fibroblastoid morphology and had no effect on hematopoiesis, and the remaining 3 cell lines could support hematopoiesis, as described in Results. The three lines were used for the following experiments.

Coculture of hematopoietic cells with stromal cells.

Stromal cells were prepared in 24- or 6-well plates. After 3 to 5 days, mouse and human hematopoietic cells were cocultured with the stromal cells. In stroma-noncontact cultures, human CB CD34+ cells were incubated in the upper compartment of transwell inserts placed on top of stromal cell layers prepared in the lower compartment of a 24-well plate (#3421; Costar, Cambridge, MA). The transwell microporous membrane of the insert cultures was a 0.4-μm microporous filter (Costar). Stroma-free cultures were established by seeding cells in the upper compartment of the transwell insert placed in empty wells. The same volume of culture medium was added to wells on day 7, and half the amount of growth medium was exchanged every week from week 2. All the plates were incubated at 37°C in a humidified atmosphere flushed with 5% CO2 in air. The cells containing stromal cells and expanded cells were harvested using 0.05% trypsin plus 0.53 mmol EDTA after a 1 to 6 weeks of incubation.

Clonal cell culture.

Methylcellulose clonal culture was performed using a modification of the technique described previously.18,19 Briefly, 1 mL of culture mixture containing cells, α-medium, 0.9% methylcellulose (Shinetsu Chemical Co, Tokyo, Japan), 30% FBS, 1% deionized fraction V bovine serum albumin (BSA; Sigma, St Louis, MO), 5 × 10−5 mol/L mercaptoethanol (Eastman Organic Chemicals, Rochester, NY), and combinations of cytokines was plated in 35-mm nontissue culture dishes (#1008; Falcon, Lincoln Park, NJ) and incubated at 37°C in a humidified atmosphere flushed with 5% CO2 in air. A combination of 100 ng/mL mSCF or hSCF, 20 ng/mL mIL-3 or hIL-3, 100 ng/mL hIL-6, 2 U/mL hEPO, 10 ng/mL hG-CSF, and 4 ng/mL hTPO was used for the determination of the murine and the human clonogenic progenitor cells, respectively. All cultures were performed in triplicate and the number of colony-forming cells (CFU-C) was scored at days 7 to 8 and days 12 to 16 of culture in mouse and human, respectively. Colony types were determined by in situ observation using an inverted microscope and according to the criteria described previously.19-21 The abbreviations used for the clonogenic progenitor cells are as follows: BFU-E, erythroid burst-forming units; CFU-GM, granulocyte-macrophage colony-forming units; CFU- Mk, megakaryocyte colony-forming units; CFU-Mix, mixed colony-forming units.

CFU-S assay.

Cells were injected into C57BL/6 mice exposed to 920 rads (60Co) of total irradiation via the tail vein. Eight and 12 days after the injection, the recipients were killed and their spleens were removed and fixed in Bouin’s solution. Macroscopic colonies (day-8- and day-12 CFU-S) were counted under a dissecting microscope.22 

Flow cytometric analysis.

Surface markers of stromal cells were analyzed by flow cytometric analysis using the FACSCalibur (Becton Dickinson, Mountain View, CA), as described.23 The cells were stained with fluorescein isothiocyanate (FITC)-conjugated antimouse CD34 (RAM34; Pharmingen, San Diego, CA), phycoerythrin (PE)-conjugated antimouse Sca-1 (E13-161.7; Pharmingen), and biotin-conjugated antimouse c-Kit (2B8), CD3 (145- 2C11), CD4 (RM4-5), CD8 (53-6.7), B220 (RA3-6B2), Mac-1 (M1/70), Gr-1 (RB6-8C5), TR119 (TER-119) vascular cellular adhesion molecule-1 (VCAM-1) (429), platelet endothelial cellular adhesion molecule-1 (PECAM-1) (MEC13.3), E-selectin (10E9.6), P-selectin (RB40.34), and CD13 (R3-242) purchased from Pharmingen, followed by PE-conjugated streptavidin (Becton Dickinson, San Jose, CA). Positivity or negativity for each antibody was determined based on cells stained with FITC-conjugated rat IgG2a (Cedarlane Laboratories, Ltd, Horndy, Canada), PE-conjugated rat IgG2b (Cedarlane Laboratories, Ltd), or only PE-conjugated streptavidin, as negative controls.

Cell sorting.

Sorting of murine and human hematopoietic progenitors was performed using described methods.23 Briefly, mouse BM MNC were incubated with PE-conjugated anti-Sca-1, allophycocyanin (APC)-conjugated anti-c-Kit (ACK-2; kindly provided by Dr Shin-Ichi Nishikawa, Kyoto University, Kyoto, Japan), and biotin-conjugated antimouse B220, Mac-1, Gr-1, CD4, CD8, and TR119 monoclonal antibodies, followed by incubation with Texas red (TR)-conjugated streptavidin (Life Technologies, Inc, Rockville, MD). The negative controls were cells stained with PE-conjugated rat IgG2a (Cedarlane Laboratories, Ltd), APC-conjugated rat IgG2b (Pharmingen), or only TR-conjugated streptavidin. Based on these controls, Linc-Kit+Sca-1+/− cells were sorted with a FACSVantage (Becton Dickinson). Human CD34+CD38+/− cells were sorted from CB MNC stained with FITC-conjugated antihuman CD34 (My10; Becton Dickinson) and PE-conjugated antihuman CD38 (HB-7; Becton Dickinson), based on cells stained with FITC- and PE-conjugated mouse IgG1 (Becton Dickinson) as the negative control.

Reverse transcription-polymerase chain reaction (RT-PCR).

Total RNA was prepared from AGM-S3 and MS-5 cells using QIAGEN RNeasy kit (Amersham, Uppsala, Sweden), incubated with deoxyribonuclease I, and reverse-transcribed using the first-strand cDNA synthesis kit (Pharmacia).

Cytokine-specific cDNAs were amplified with Taq DNA polymerase, using pairs of oligonucleotide primers as follows24-26: IL-3-5′, TCAGACTTTAGGTGCTCTGC-3′; IL-3-3′, TCGTGGAAAGCCAAGGAGAA-3′; IL-6-5′, GATAGTCAATTCCAGAAACCGCTA-3′; IL-6-3′, TACTCCAGGTAGCTATGGTACTCC-3′; oncostatin M (OSM)-5′, TCCGCCTCCAAAACCTGAACAC-3′; OSM-3′, TCTGTGTGGGCTCAGGTATCT-3′; leukemia inhibitory factor (LIF)-5′, GGAGTCCAGCCCATAATGAAGGTC-3′; LIF-3′, GGCCTGGACCACCACACTTATGAC-3′; G-CSF-5′, GACGGCTCGCCTTGCTCTGCACCA-3′; G-CSF-3′, ACCTGGCTGCCACTGTTTCTT-TAGG-3′; granulocyte-macrophage colony-stimulating factor (GM-CSF)-5′, AGAAGCTAACATGTGTGCAGACCCG-3′; GM-CSF-3′, ATTCCAAGTTCCTGGCTCATTACGC-3′; macrophage colony-stimulating factor (M-CSF)-5′, GACAGGCCGTTGACAGAGGTGAACCC-3′; M-CSF-3′, ATAGAATCCTTTCT-ATACTGGCAGTTC-3′; SCF-5′, AAAGTAAAACTCGAGATGAAGAAGACACAAACTTGG-3′; SCF-3′, TTTGACTTTTTAATTAATTAGGCTGCAACAGGGGGTAACAT-3′; Flk2 ligand (FL)-5′, AAAGAAAAACTCGAGATGACAGTGCAGGCGCCAGCC-3′; FL-3′, TTTGACTTTTTAATTAATTACTGCCT GGGCCGAGGCTCTGG-3′; TPO-5′, CAGGACCACAGCTCACAAGGAC-3′; TPO-3′, CCATTCACAGGTCCGTGTGTCC-3′; IL-11-5′, CTCTGGCCAGATAGAGTCGTTG-3′; IL-11-3′, CACGGCGCAGCCATTGTACATG-3′; HPRT-5′, CCTGCTGGATTACATTAAAG CACTG-3′; HPRT-3′, GTCAAGGGCATATCCAACAACAAAC-3′. Samples were denatured at 94°C for 3 minutes, followed by amplification rounds consisting of 94°C for 1 minute (denaturing); 55°C to 65°C for 2 minutes (annealing), and 72°C for 3 minutes (extension) for 40 cycles. Products were separated on a 1.0% agarose gel, stained with ethidium bromide, and photographed.

Transplantation into NOD/SCID mice.

CB MNC (1 × 106) and those cultured with stromal cells for 4 weeks were injected into 8- to 10-week-old NOD/Shi-scid (NOD/SCID) mice irradiated with 300 rads (60Co) of total irradiation through the tail vein. Because natural killer cell activity of NOD/Shi-scid mice is not so low,27 the recipient mice were injected intraperitoneally with 300 mL of PBS containing 20 mL of anti-asialo GM1 antibody (Wako, Osaka, Japan) immediately before the cell transplantation and on day 11 of transplantation. Mice were killed 5 weeks after the transplantation, and BMC were collected. The presence of human hematopoietic cells was determined by detection of cells positively stained with FITC-conjugated antihuman CD45 in flow cytometric analysis. Specific subsets of human hematopoietic cells were quantified by gating on human CD45-PE-cyanine 5-succinimidylester (PECy5)-positive cells and then assessing staining with antihuman CD13-PE, CD33-PE, CD14-PE, CD10-FITC, CD19-PE, CD3-FITC, and CD34-FITC. All antibodies were from Becton Dickinson except for antihuman CD34-FITC (Immunoteck, Marseille, France). Human hematopoietic cells were also determined by detection human ALU sequence in DNA of the BMC by PCR analysis. For PCR analysis, DNA extracted from the BMC was subjected to PCR amplification using as primers the following human ALU28 and mouse β-actin29 sequences: ALU-5′, CACCTGTAATCCCAGCAGTTT-3′; ALU-3′, CGCGATCTCGGCTCACTGCA-3′; β-actin-5′, GTGGGCCGCTCTAGGCACCAA-3′, β-actin-3′, CTCTTTGATGTCACGCACGATTTC-3′.

Establishment of stromal cell lines from 10.5 dpc mouse embryo AGM region.

Three stromal cell lines, AGM-S1, 2, and 3, were obtained from the 10.5 dpc mouse embryo AGM region. They were maintained in α-medium containing 10% FBS in 25-cm2 flasks at 37°C in a humidified atmosphere flushed with 5% CO2 in air. These conditions led to doubling times of 5 to 7 days and 100% viability. The photomicograph (Fig 1A) shows the appearance of one of these, AGM-S3. AGM-S3 cells had large, flat cell morphology with widely spread cytoplasm, and some of them converted to fat-containing cells in confluent culture. AGM-S1 and AGM-S2 cells manifested a similar morphology to AGM-S3 cells.

Fig. 1.

(A) Phase microscopy of AGM-S3 cells established. (B) Appearance of cobblestone-like colonies generated in the coculture of human CB CD34+ cells with AGM-S3 cells at day 14 of culture. (C) Appearance of a part of a mixed hematopoietic colony produced by the cells harvested from the coculture of CD34+CD38 cells with AGM-S3 cells at week 6 of culture.

Fig. 1.

(A) Phase microscopy of AGM-S3 cells established. (B) Appearance of cobblestone-like colonies generated in the coculture of human CB CD34+ cells with AGM-S3 cells at day 14 of culture. (C) Appearance of a part of a mixed hematopoietic colony produced by the cells harvested from the coculture of CD34+CD38 cells with AGM-S3 cells at week 6 of culture.

Close modal
Effect of AGM-S1, 2, and 3 cells on mouse BM progenitor cells.

We first examined the effect of AGM-S1, 2, and 3 stromal cells on adult hematopoietic cells in the coculture with BMC of C57BL/6 mice. When 1 × 105 BMC were plated on the stromal cell layers, cobblestone-like colonies appeared under the stromal layers at day 3 of incubation and then gradually increased. The colonies in the cocultures with AGM-S1 and 3 cells were almostly twice the number of those with AGM-S2 cells at day 7 (Table 1). Clonal assay of the cells in the coculture at day 7 of incubation showed that the three cell lines supported the expansion of CFU-C. However, the numbers of CFU-C in the cocultures with AGM-S1 and 3 cells were approximately 5 to 7 times larger than that with AGM-S2 cells. Day-8 and day-12 CFU-S also expanded at day 7 of the coculture with AGM-S1 and 3 cells. This result indicates that AGM-S1, 2, and 3 cells are able to promote the proliferation of hematopoietic progenitors without any exogenous cytokines, but AGM-S2 cells seem to have less ability on murine hematopoietic progenitors than do AGM-S1 and 3 cells.

Table 1.

Coculture of Mouse BMC With AGM-S1, 2, and 3 Cells

Cell Line No. of Cobblestone/Well No. of CFU-C/Well No. of CFU-S 8/Well No. of CFU-S 12/Well
AGM-S 1 230 ± 16  3,448 ± 131  24 ± 4  16 ± 2 
AGM-S 2  126 ± 23  768 ± 59  ND ND  
AGM-S 3  260 ± 44  5,496 ± 184 20 ± 2  18 ± 3 
Cell Line No. of Cobblestone/Well No. of CFU-C/Well No. of CFU-S 8/Well No. of CFU-S 12/Well
AGM-S 1 230 ± 16  3,448 ± 131  24 ± 4  16 ± 2 
AGM-S 2  126 ± 23  768 ± 59  ND ND  
AGM-S 3  260 ± 44  5,496 ± 184 20 ± 2  18 ± 3 

Cell layers of each line were established in 6-well plates. BMC (1 × 105 per well) were planted on stromal cell layers. BMC (1 × 105) contained 615 ± 40 of CFU-C, 11 ± 2 of day-8 CFU-S, and 6 ± 1 of day-12 CFU-S. The CFU-C were counted at day 8. The number of colonies indicates the mean ± SD of triplicate cultures.

Abbreviation: ND, not determined.

Effect of AGM-S3 cells on Linc-Kit+Sca-1+/−mouse BMC.

To investigate the effect of AGM-S3 cells on murine hematopoietic progenitors in more detail, sorted Linc-Kit+Sca-1+ and Linc-Kit+Sca-1 cells shown to contain murine primitive hematopoietic cells and more mature ones, respectively,30 were cocultured with AGM-S3 cells, which were considered to be the most potent stimulator on murine hematopoietic progenitors among the three cell lines (Table 2). When 100 sorted Linc-Kit+Sca-1 cells were cocultured with AGM-S3 cells, no hematopoietic progenitors were detected in the coculture at day 10 of culture. By contrast, in the culture of 100 Linc-Kit+Sca-1+cells, all types of progenitors, including CFU-GM, BFU-E, CFU-Mk, CFU-Mix, and day-8 and day-12 CFU-S, showed a remarked expansion. In particular, CFU-Mix and day-12 CFU-S, immature hematopoietic progenitors, increased 80-fold and 10-fold, respectively, and remained detectable after 6 weeks of coculture of AGM-S3 cells with Linc-Kit+Sca-1+ cells (data not shown). Thus, most of hematopoietic progenitors expanded in the coculture with AGM-S3 cells were derived from Linc-Kit+Sca-1+ cells, indicating that AGM-S3 cells act on primitive hematopoietic cells of the adult mouse.

Table 2.

Coculture of Linc-Kit+Sca-1+/− Cells With AGM-S3 Cells

Cultured Cells Days of CocultureNo. of Progenitors/Well
CFU-GM BFU-ECFU-Mk CFU-Mix Day-12 CFU-S
Linc-Kit+Sca-1 15 ± 2  26 ± 3  0 ± 1  0  
 10  0  0  0  
Linc-Kit+Sca-1+ 11 ± 2  0  4 ± 2  24 ± 3  3 ± 1 
 10  2,440 ± 128  80 ± 20  120 ± 40 200 ± 60  26 ± 4 
Cultured Cells Days of CocultureNo. of Progenitors/Well
CFU-GM BFU-ECFU-Mk CFU-Mix Day-12 CFU-S
Linc-Kit+Sca-1 15 ± 2  26 ± 3  0 ± 1  0  
 10  0  0  0  
Linc-Kit+Sca-1+ 11 ± 2  0  4 ± 2  24 ± 3  3 ± 1 
 10  2,440 ± 128  80 ± 20  120 ± 40 200 ± 60  26 ± 4 

Cell layers of AGM-S3 cells were established in 24-well plates. Linc-Kit+Sca-1+/− cells (100/well) were planted on AGM-3 cell layers. Clonogenic progenitors generated in the culture at day 10 were evaluated by culturing a fraction of cells harvested. The assay for CFU-S was performed as described in Materials and Methods. The number of colonies indicates the mean ± SD of triplicate cultures.

Effect of AGM-S1, 2, and 3 and MS-5 cells on human CB CD34+ cells.

Some murine stromal cell lines have been shown to support human hematopoiesis.31 For example, MS-5 cells,17 a stromal cell line esablished from adult mouse BMC, can stimulate proliferation of human hematopoietic progenitors.31 We then cocultured human CB CD34+ cells with AGM-S1, 2, and 3 and MS-5 cells to examine the effect of these stromal cells on human hematopoietic progenitors. Five hundred human CB CD34+cells were cocultured with AGM-S1, 2, and 3 and MS-5 cells prepared in 24-well plates. At days 7 to 10 of incubation, cobblestone-like colonies appeared under these stromal cells (Fig 1B), and nonadherent hematopoietic cells continued to be released into the culture medium after day 14. Clonal assay of the cells harvested from the coculture at week 3 of incubation showed that all the cell lines stimulated the expansion of human CB hematopoietic progenitors, but AGM-S1 and 3 cells again showed more significant stimulatory activity than AGM-S2, and MS-5 cells showed similar effects to AGM-S2 cells (Table 3). The number of total progenitors on AGM-S1, 2, and 3 and MS-5 cells increased 5.3-fold, 3-fold, 4.8-fold, and 2.3-fold, respectively, at week 3 of culture. Although clonogenic progenitors were detectable after 6 weeks of incubation with these stromal cells, the numbers of progenitors in coculture with AGM-S1 and 3 cells were approximately 5 times that with AGM-S2 and MS-5 cells. Interestingly, all of the CFU-GM, BFU-E, and CFU-Mix were present in cocultures with AGM-S1 and 3 cells, whereas only CFU-GM were detected in coculture with AGM-S2 and MS-5 cells at 6 weeks of culture. This result indicates that AGM-S1 and 3 cells are more potent stimulators than AGM-S2 and MS-5 cells on human CB hematopoietic cells.

Table 3.

Coculture of Human CB CD34+ Cells With AGM-S1, 2, and 3 and MS-5 Cells

Duration of Coculture Cell LineNo. of Progenitors/Well
CFU-GM BFU-ECFU-Mix Total
0   32 ± 6  13 ± 2 32 ± 5  77 ± 9  
3 wk  AGM-S 1  310 ± 30 10 ± 5  90 ± 20  410 ± 50  
 AGM-S 2 210 ± 25  0  20 ± 10  230 ± 40 
 AGM-S 3  230 ± 20  20 ± 5  110 ± 30 360 ± 30  
 MS-5  180 ± 30  0  180 ± 30  
6 wk  AGM-S 1  100 ± 12 2 ± 2  20 ± 8  122 ± 16  
 AGM-S 2 24 ± 6  0  0  24 ± 6  
 AGM-S 3  56 ± 6  4 ± 2  24 ± 8  84 ± 16 
 MS-5  24 ± 4  0  24 ± 4 
Duration of Coculture Cell LineNo. of Progenitors/Well
CFU-GM BFU-ECFU-Mix Total
0   32 ± 6  13 ± 2 32 ± 5  77 ± 9  
3 wk  AGM-S 1  310 ± 30 10 ± 5  90 ± 20  410 ± 50  
 AGM-S 2 210 ± 25  0  20 ± 10  230 ± 40 
 AGM-S 3  230 ± 20  20 ± 5  110 ± 30 360 ± 30  
 MS-5  180 ± 30  0  180 ± 30  
6 wk  AGM-S 1  100 ± 12 2 ± 2  20 ± 8  122 ± 16  
 AGM-S 2 24 ± 6  0  0  24 ± 6  
 AGM-S 3  56 ± 6  4 ± 2  24 ± 8  84 ± 16 
 MS-5  24 ± 4  0  24 ± 4 

Cell layers of each line were established in 24-well plates. Five hundred human CB CD34+ cells per well were planted on the stromal cell layers and cultured for 6 weeks. Clonogenic progenitors generated in the culture at each time point were evaluated by culturing a fraction of the cells harvested. The colonies were counted at day 14. The number of colonies indicates the mean ± SD of triplicate cultures.

Effect of AGM-S3 cells on human CB CD34+CD38+/− cells.

To examine whether AGM-S3 cells act on human primitive hematopoietic progenitor cells, we compared the effects of AGM-S3 cells on CD34+CD38 and CD34+CD38+ cells, which have been shown to reflect human primitive hematopoietic cells and more mature populations, respectively32(Table 4). When both fractions sorted from CB MNC were cocultured with AGM-S3 cells, hematopoietic progenitors generated from CD34+CD38+ cells exceeded those from CD34+CD38 cells at week 4 of incubation. However, at week 6, numbers of progenitors from CD34+CD38 cells surpassed those from CD34+CD38+ cells, and neither BFU-E nor CFU-Mix were detectable in the culture of CD34+CD38+cells, whereas progenitors from CD34+CD38cells contained 7% of BFU-E and 20% of CFU-Mix (Fig 1C). The result indicates that AGM-S3 cells act on both CD34+CD38+ and CD34+CD38 cells and that the generation of CFU-Mix, immature multipotential progenitors, from CD34+CD38 primitive hematopoietic cells was supported by AGM-S3 cells at least for 6 weeks.

Table 4.

Coculture of CD34+CD38+/−Cells With AGM-S3 Cells

Duration of Coculture Cultured CellsNo. of Progenitors/Well
CFU-GM BFU-ECFU-Mix Total
0  CD34+CD38+ 150 ± 25  105 ± 15  50 ± 5  305 ± 40 
 CD34+CD38 25 ± 5 10 ± 3  30 ± 6  65 ± 8  
4 wk CD34+CD38+ 560 ± 40  40 ± 5 386 ± 45  986 ± 90 
 CD34+CD38 120 ± 20 20 ± 5  136 ± 20  276 ± 56  
6 wk CD34+CD38+ 210 ± 40  0  210 ± 40 
 CD34+CD38 310 ± 30 30 ± 10  90 ± 30  430 ± 40 
Duration of Coculture Cultured CellsNo. of Progenitors/Well
CFU-GM BFU-ECFU-Mix Total
0  CD34+CD38+ 150 ± 25  105 ± 15  50 ± 5  305 ± 40 
 CD34+CD38 25 ± 5 10 ± 3  30 ± 6  65 ± 8  
4 wk CD34+CD38+ 560 ± 40  40 ± 5 386 ± 45  986 ± 90 
 CD34+CD38 120 ± 20 20 ± 5  136 ± 20  276 ± 56  
6 wk CD34+CD38+ 210 ± 40  0  210 ± 40 
 CD34+CD38 310 ± 30 30 ± 10  90 ± 30  430 ± 40 

AGM-S3 cell layers were established in 24-well plates. Five hundred CD34+CD38+/− cells were planted on stromal cell layers. Clonogenic progenitors generated in the culture at each time point were evaluated by culturing a fraction of cells harvested. The number of colonies indicates the mean ± SD of triplicate cultures.

Effect of AGM-S3 cells on human reconstituting hematopoietic stem cells.

To investigate the effect of AGM-S3 cells on human reconstituting hematopoietic stem cells, we performed transplantation experiments using NOD/SCID mice and examined the reconstituting abilities of CB MNC before and after the coculture with AGM-S3 cells. When 1 × 106 CB MNC cocultured with AGM-S3 cells for 4 weeks were transplanted into NOD/SCID mice, human CD45+ cells were found in BMC of the recipient mice, as determined by flow cytometry (Fig 2A) after 5 weeks of transplantation. Chimerism percentages of human CD45+ cells in BMC were 6.2% and 5.2% in the mice transplanted with CB MNC before and after the coculture, respectively. Human CD45+ cells in BMC of the mouse transplanted with cocultured CB MNC were further analyzed to determine multilineage reconstitution. In human CD45+cells, 29% of CD13+ cells, 38% of CD33+cells, 12% of CD14+ cells, 58% of CD19+cells, and 8% of CD34+ cells, but no CD3+cells, were detected (Fig 2B and data not shown). The presence of human hematopoietic cells in the recipient BMC was also confirmed by the detection of human ALU sequences in PCR analysis of the BMC DNA (data not shown). Hence, AGM-S3 cells can also support survival or self-renewal of human reconstituting stem cells at least for 4 weeks.

Fig. 2.

(A) Expression of human CD45 antigen on BMC collected from NOD/SCID mice untransplanted (a) and transplanted with inoculated 1 × 106 CB MNC (b) and those cocltured with AGM-S3 for 4 weeks (c). (B) Specific subsets of human hematopoietic cells in BMC of the NOD/SCID mouse transplanted with cocultured human CB MNC quantified by gating on human CD45-PECy5-positive cells and then assessing staining with antihuman CD13- PE, CD33-PE, CD14-PE, CD19-PE, and CD34-FITC. BMC of the recipient mouse were collected 5 weeks after transplantation.

Fig. 2.

(A) Expression of human CD45 antigen on BMC collected from NOD/SCID mice untransplanted (a) and transplanted with inoculated 1 × 106 CB MNC (b) and those cocltured with AGM-S3 for 4 weeks (c). (B) Specific subsets of human hematopoietic cells in BMC of the NOD/SCID mouse transplanted with cocultured human CB MNC quantified by gating on human CD45-PECy5-positive cells and then assessing staining with antihuman CD13- PE, CD33-PE, CD14-PE, CD19-PE, and CD34-FITC. BMC of the recipient mouse were collected 5 weeks after transplantation.

Close modal
Surface molecule expression of AGM-S3 cells.

We investigated the characteristics of AGM-S3 cells using flow cytometric analysis. Our result (Fig 3 and data not shown) showed that hematopoietic lineage markers such as CD3, CD4, CD8, B220, Mac-1, Gr-1, and TR119 were undetectable on the surface of AGM-S3 cells. Adhesion molecules, VCAM-1 but no PECAM-1, E-selectin, and P-selectin were expressed on AGM-S3 cells. AGM-S3 cells also expressed CD13 and Sca-1, but not c-Kit and CD34.

Fig. 3.

Flow cytometric analysis of surface markers of AGM-S3 cells. AGM-S3 cells were stained with biotin-conjugated antimouse CD3, B220, Mac-1, Gr-1, VCAM-1, PECAM-1, E-selectin, P-selectin, and CD13, followed by PE-conjugated streptavidin (A through I), PE-conjugated antimouse Sca-1 and c-Kit (J and K), and FITC-conjugated antimouse CD34 (L).

Fig. 3.

Flow cytometric analysis of surface markers of AGM-S3 cells. AGM-S3 cells were stained with biotin-conjugated antimouse CD3, B220, Mac-1, Gr-1, VCAM-1, PECAM-1, E-selectin, P-selectin, and CD13, followed by PE-conjugated streptavidin (A through I), PE-conjugated antimouse Sca-1 and c-Kit (J and K), and FITC-conjugated antimouse CD34 (L).

Close modal
Cytokine expression by AGM-S3 and MS-5 cells.

We then compared cytokine expression between AGM-S3 cells and MS-5 cells by RT-PCR (Fig 4). Both AGM-S3 and MS-5 cells showed detectable levels of SCF, IL-6, and OSM, but undetectable levels of IL-3, LIF, G-CSF, GM-CSF, IL-11, TPO, and FL. MS-5 cells, but not AGM-S3 cells, showed a detectable level of M-CSF.

Fig. 4.

RT-PCR analysis of expression of various cytokines on AGM-S3 and MS-5 cells.

Fig. 4.

RT-PCR analysis of expression of various cytokines on AGM-S3 and MS-5 cells.

Close modal
Effect of conditioned medium of AGM-S3 cells on human CB CD34+ cells.

To examine the effect of conditioned medium of AGM-S3 cells, human CB CD34+ cells were plated either in stroma-contact cultures with AGM-S3 cells or in transwell inserts placed above the stromal cell layers (stroma-noncontact cultures; Table5). CD34+ cells were also cultured in transwell inserts placed in empty wells as controls (stroma-free cultures), where only few or no clonogenic cells were detected at weeks 2 and 4 of incubation. The number of total clonogenic progenitors decreased at both weeks 2 and 4 in stroma-noncontact cultures, whereas it increased 4-fold and 3.2-fold in stroma-contact cultures, respectively. The number of progenitors in stroma- contact cultures were more than 7 times than that in stroma-noncontact cultures at week 4. Moreover, all of CFU-GM, BFU-E, and CFU-Mix were present in stroma-contact cultures, whereas only CFU-GM were detected in stroma-noncontact cultures. These results indicates that the direct interaction between AGM-S3 and human hematopoietic cells is involved in the stimulation of human hematopoietic cells, especially primitive hematopoietic cells.

Table 5.

Stroma-Contact or Stroma-Noncontact Cocultures of Human CB CD34+ Cells With AGM-S3 Cells

Duration of Coculture Culture Conditions No. of Progenitors/Well
CFU-GMBFU-E CFU-Mix Total
0   56 ± 6  26 ± 4 54 ± 12  136 ± 16  
2 wk  Stroma-free 8 ± 3  0  0  8 ± 3 
 Noncontact  96 ± 16  0  96 ± 16  
 Contact  248 ± 36  180 ± 28 108 ± 20  536 ± 56  
4 wk  Stroma-free 0  0  0  
 Noncontact  64 ± 12  0  64 ± 12  
 Contact  430 ± 40  80 ± 20 60 ± 10  430 ± 40 
Duration of Coculture Culture Conditions No. of Progenitors/Well
CFU-GMBFU-E CFU-Mix Total
0   56 ± 6  26 ± 4 54 ± 12  136 ± 16  
2 wk  Stroma-free 8 ± 3  0  0  8 ± 3 
 Noncontact  96 ± 16  0  96 ± 16  
 Contact  248 ± 36  180 ± 28 108 ± 20  536 ± 56  
4 wk  Stroma-free 0  0  0  
 Noncontact  64 ± 12  0  64 ± 12  
 Contact  430 ± 40  80 ± 20 60 ± 10  430 ± 40 

AGM-S3 cell layers were prepared in 24-well plates. Five hundred human CB CD34+ cells per well were planted on the stromal cell layers (contact), in transwell inserts placed above the stromal cell layers (noncontact), or in transwell inserts placed in empty wells (stroma-free). Clonogenic progenitors generated in the culture at each time point were evaluated by culturing the total or a fraction of the cells harvested. The colonies were counted at day 14 of culture. The number of colonies indicates the mean ± SD of triplicate cultures.

There is abundant evidence to indicate that microenvironmental stroma within the hematopoietic tissues play important roles in the support and regulation of hematopoiesis.5,33 Stroma is composed of heterogeneous cell populations and an extracellular matrix (ECM) that constitute a suitable microenvironment for the proliferation and differentiation of hematopoietic stem/progenotor cells.34Not only the cytokines locally produced by stroml cells,35but also cell-to-cell36 and cell-to-extracellular matrix contacts37,38 are known to be involved in the maintenance of hematopoiesis. To make the mechanisms clear, several stromal cell lines have been established from fetal and adult mouse hematopoietic tissues, such as MS-5 from adult BM,17 PA-6 from newborn calvaria,6 SPY3-2 from adult spleen,7CD34+ endothelial cells from yolk sac,8 and AFT024 cells from fetal liver,9 some of which can support the long-term survival of murine LTR-HSC.9 

Recent evidence shows that the microenvironment of AGM region plays important roles in the self-renewal and expansion of hematopoietic stem cells.14 Hence, we established three stromal cell lines, AGM-S1, 2, and 3, from 10.5 dpc mouse embryo AGM region. Among these three cell lines, which were similar in apperance, AGM-S1 and 3 cells showed more significant stimulatory activity to proliferate murine and human primitive hematopoietic progenitors than AGM-S2 cells. The expression of CD13 and VCAM-1 on AGM-S3 cells may indicate the stromal cells possess the character of endothelial cells to some extent. AGM-S3 also expressed Sca-1, which was reported to be detected in 10 dpc mouse embryo AGM region39 and endothelial cells.40Recently, Satoh et al41 reported that the expression level of Sca-1 in PA-6 cells correlate with their hematopoietic supporting activity.

The activity of the stromal cells on murine hematopoiesis was confirmed by the expansion of CFU-C and day-8- and day-12 CFU-S in the coculture wih murine BMC. The coculture of AGM-S3 cells with sorted hematopoietic progenitor cells showed that these expanded progenitors were derived from Linc-Kit+Sca-1+ cells, indicating that AGM-S3 cells act on primitive hematopoietic progenitors.

Some evidence has accumulated showing that human hematopoiesis can develop in a nonhuman environment.31,42,43 For example, MS-5 cells can support human hematopoiesis successfully, as shown by the present and previous studies. Issaad et al31 reported that MS-5 cells supported the generation of various hematopoietic progenitors, including CFU-Mix from human BM CD34+CD38 cells in long-term culture. In contract, Nishi et al42 showed that MS-5 cells were able to support the generation of CFU-GM, but not CFU-Mix from CB CD34+CD38 cells, in accordance with our studies. Our data presented here demonstrated that AGM-S3 cells also promoted the expansion of human CB hematopoietic progenitor cells without the addition of human growth factors. When CB CD34+CD38 cells were cocultured with AGM-S3 and MS-5 cells, only AGM-S3 cells supported the generation of CFU-Mix, at least for 6 weeks. Moreover, we performed experiments using NOD-SCID mice to examine the effect of AGM-S3 cells on human hematopoietic stem cells. The result indicated that AGM-S3 cells had the ability to maintain the survival or self-renewal of human reconstituting hematopoietic stem cells for more than 4 weeks. These results suggest that AGM-S3 cells have more potent stimulatory activity in human primitive hematopoiesis than MS-5 cells.

Little is known on how murine stromal cells stimulate human hematopoietic cells, but the involvement of growth factor(s) with species-cross activity produced by stromal cells is most likely. In RT-PCR analysis, AGM-S3 cells produced detectable levels of SCF, IL-6, and OSM, but no detectable levels of M-CSF, IL-3, LIF, G-CSF, GM-CSF, IL-11, TPO, and FL. Our data and previous reports44 showed that the cytokine expression of AGM-S3 cells was similar to that of MS-5 cells, except for the expression of M-CSF. It is of interest that M-CSF is expressed on MS-5 but not on AGM-S3 cells. OP9 stromal cells lacking M-CSF were found to support murine primitive hematopoietic progenitors45 and embryonic stem cells.46Because the combination of SCF and IL-6 stimulates the proliferation of murine primitive hematopoietic progenitors47 and OSM has been shown to induce hematopoiesis in the 11.5 dpc mouse AGM region,48 these cytokines may be involved in expansion of the murine primitive hematopoietic progenitors observed in the present study. However, mouse IL-6 and OSM have no apparent effects on human cells.49 Although mouse SCF has cross-activity with human SCF, mouse SCF alone or in combination with mouse IL-6 and OSM could not support human clonogenic progenitors for 6 weeks (data not shown). Therefore, AGM-S3 cells seem to express species-cross reactive molecule(s) other than the cytokines we examined and that act on primitive hematopoietic cells.

Because the production of clonogenic progenitors in stroma-noncontact cultures were higher than that in stroma-free cultures, soluble form factor(s) was produced by AGM-S3 cells. However, the direct contact between AGM-S3 and CD34+ cells was required for the optimal stimulation of clonogenic progenitors, and the generation of CFU- Mix and BFU-E was detected only in stroma-contact cultures. Although the effect seen in this experiment may have been limited by factor concentration, stability, or dependence on ECM attachment, the result suggests a possibility that membrane-bound molecule(s) plays some roles in the expansion of primitive hematopoietic cells by AGM-S3 cells. Detection and characterization of the molecule(s) from AGM-S3 cells may contribute toward understanding of regulatory mechanisms in the development of primitive hematopoietic stem and progenitor cells and provide a novel strategy for ex vivo expansion of human transplantable HSC.

The authors thank M. Nishihara and A. Kaneko for technical support, Drs K. Kobayashi and Y. Ueyama for collaboration, and M. Ohara for comments on the manuscript.

Supported by grant from the Ministry of Education, Science, Sports and Culture, Japan.

Address reprint requests to Tatsutoshi Nakahata, MD, Department of Clinical Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108, Japan; e-mail:nakahata@ims.u-tokyo.ac.jp.

The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" is accordance with 18 U.S.C. section 1734 solely to indicate this fact.

1
Ogawa
 
M
Differentiation and proliferation of hematopoietic stem cells.
Blood
81
1993
2844
2
Bhatia
 
M
Bonnet
 
D
Kapp
 
U
Wang
 
JCY
Murdoch
 
B
Dick
 
JE
Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture.
J Exp Med
186
1997
619
3
Conneally
 
E
Cashman
 
J
Petzer
 
A
Eaves
 
C
Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diebetic-scid/scid mice.
Proc Natl Acad Sci USA
94
1997
9836
4
Miller
 
CL
Eaves
 
CJ
Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho- myeloid recostituting ability.
Proc Natl Acad Sci USA
94
1997
13648
5
Wolf
 
NS
The hemopoietic microenvironment.
Clin Haematol
8
1979
469
6
Kodama
 
H
Amagai
 
Y
Koyama
 
H
Kasai
 
S
A new preadipose cell line derived from newborn mouse calvaria can promote the proliferation of pluripotent hemopoietic stem cells in vitro.
J Cell Physiol
112
1982
89
7
Tsuchiyama
 
J
Mori
 
M
Okada
 
S
Murine spleen stromal cell line SPY3-2 maintains long-term hematopoiesis in vitro.
Blood
85
1995
3107
8
Fennie
 
C
Cheng
 
D
Dowbenko
 
P
Young
 
P
Lasky
 
LA
CD34+ endothelial cell lines derived from murine Yolk Sac induce the proliferation and differentiation of yolk sac CD34+ hematopoietic progenitors.
Blood
86
1995
4454
9
Moore
 
KA
Ema
 
H
Lemischka
 
IR
In vitro maintenance of highly purified, transplantable hematopoietic stem cells.
Blood
89
1997
4337
10
Bernstein
 
SE
Blood and blood formation
Green
 
EL
Biology of the Laboratory Mouse
2
1966
351
McGraw-Hill
New York, NY
11
Godin
 
I
Dieterlen-Lievre
 
F
Cumano
 
A
Emergence of multipotent hematopoietic cells in the yolk sac and paraaortic splanchnopleura in mouse embryos, beginning at 8.5 days postcoitus.
Proc Natl Acad Sci USA
92
1995
773
12
Medvinsky
 
AL
Samoylina
 
NL
Muller
 
AM
Dzierzak
 
EA
An early pre-liver intraembryonic source of CFU-S in the developing mouse.
Nature
364
1993
64
13
Yoder
 
MC
Hiatt
 
K
Dutt
 
P
Mukherjee
 
P
Bodine
 
D
Olic
 
D
Characterization of definitive lymphohematopoietic stem cells in the day 9 murine yolk sac.
Immunity
7
1997
335
14
Medvinsky
 
AL
Dzierzak
 
EA
Definitive hematopoiesis is autonomously initiated by the AGM region.
Cell
86
1996
897
15
Muller
 
AM
Medvinsky
 
AL
Strouboulis
 
J
Grosveld
 
F
Dzierzak
 
EA
Development of hematopoietic stem cell activity in the mouse embryo.
Immunity
1
1994
291
16
Sui
 
X
Tsuji
 
K
Tanaka
 
R
Tajima
 
S
Muraoka
 
K
Ebihara
 
Y
Ikebuchi
 
K
Yasukawa
 
K
Taga
 
T
Kishimoto
 
T
Nakahata
 
T
gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells.
Proc Natl Acad Sci USA
92
1995
2859
17
Itoh
 
K
Tezuka
 
H
Sakoda
 
H
Konno
 
M
Nagata
 
K
Uchiyama
 
T
Uchino
 
H
Mori
 
KJ
Reproducible establishment of hemopoietic supportive stroma cell lines from murine bone marrow.
Exp Hematol
17
1989
145
18
Nakahata
 
T
Ogawa
 
M
Identification in culture of a class of hemopoietic colony-forming units with extensive capability to self-renew and generate multipotential hemopoietic colonies.
Proc Natl Acad Sci USA
79
1982
3843
19
Nakahata
 
T
Ogawa
 
M
Hemopoietic colony-forming cells in umbilical cord blood with extensive capability to generate mono- and multipotential hemopoietic progenitors.
J Clin Invest
70
1982
1324
20
Nakahata
 
T
Ogawa
 
M
Clonal origin of murine hemopoietic colonies with apparent restriction to granulocyte- macrophage-megakaryocyte (GMM) differentiation.
J Cell Physiol
111
1982
239
21
Imai
 
T
Koike
 
K
Kubo
 
T
Kikuchi
 
T
Amano
 
Y
Takagi
 
M
Okumura
 
N
Nakahata
 
T
Interleukin-6 supports human megakaryocytic proliferation and differentiation in vitro.
Blood
78
1991
1969
22
Till
 
J
McCulloch
 
EA
A direct measurement of the radiation sensitivity of normal mouse bone marrow cells.
Radiat Res
14
1961
213
23
Tajima
 
S
Tsuji
 
K
Ebihara
 
Y
Sui
 
X
Tanaka
 
R
Muraoka
 
K
Yoshida
 
M
Yamada
 
K
Yasukawa
 
K
Taga
 
T
Kishimoto
 
T
Nakahata
 
T
Analysis of interleukin 6 receptor and gp130 expressions and proliferative capability of human CD34+ cells.
J Exp Med
184
1996
1357
24
Szilvassy
 
SJ
Weller
 
KP
Lin
 
W
Sharma
 
AK
Ho
 
ASY
Tsukamoto
 
A
Hoffman
 
R
Leiby
 
KR
Gearing
 
DP
Leukemia inhibitory factor upregulates cytokine expression by a murine stroma cell line enabling the maintenance of highly enriched competitive repopulating stem cells.
Blood
87
1996
4618
25
Wineman
 
J
Moore
 
K
Lemischka
 
I
Muller-Sieburg
 
C
Functional heterogeneity of the hematopoietic microenvironment: Rare stromal elements maintain long-term repopulating stem cells.
Blood
87
1996
4082
26
Keller
 
G
Kennedy
 
M
Papaynnopoulou
 
T
Wiles
 
MV
Hematopoietic commitment during embryonic stem cell differentiation in culture.
Mol Cell Biol
13
1993
473
27
Koyanagi
 
Y
Tanaka
 
Y
Kira
 
J
Ito
 
M
Hioki
 
K
Misawa
 
N
Kawano
 
Y
Yamasaki
 
K
Tanaka
 
R
Suzuki
 
Y
Ueyama
 
Y
Terada
 
E
Tanaka
 
T
Miyasaka
 
M
Kobayashi
 
T
Kumasawa
 
Y
Yamanoto
 
N
Primary human immunodeficiency virus type 1 viremia and cental nervous system invasion in a novel hu-PBL-immunodeficient mouse stain.
J Virol
71
1997
2417
28
Cesano
 
A
Hoxie
 
JA
Lange
 
B
Nowell
 
PC
Bishop
 
J
Santoli
 
D
The severe combined immunodeficience (SCID) mouse as a model for human myeloid leukemias.
Oncogen
7
1992
827
29
Alonso
 
S
Minty
 
A
Bourlet
 
Y
Buckingham
 
M
Comparison of three actin-coding sequences in the mouse; evolutionary relationships between the actin genes of warm-blooded vertebrates.
J Mol Evol
23
1986
11
30
Okada
 
S
Nakauchi
 
H
Nagayoshi
 
K
Nishikawa
 
S
Miura
 
Y
Suda
 
T
In vivo and in vitro stem cell function of c-kit and Sca-1 positive murine hematopoietic cells.
Blood
80
1992
3044
31
Issaad
 
C
Croisille
 
L
Katz
 
A
Vainchenker
 
W
Coulombel
 
L
A murine stromal cell line allows the proliferation of very primitive human CD34++/CD38− progenitor cells in long-term cultures and semisolid assays.
Blood
81
1993
2916
32
Hao
 
QL
Shah
 
AJ
Thiemann
 
FT
Smogorzewska
 
EM
Crooks
 
GM
A functional comparison of CD34+CD38− cells in cord blood and bone marrow.
Blood
86
1995
3745
33
Trentin
 
JJ
Influence of hematopoietic organ stroma (hematopoietic inductive microenvironment) on stem cell differentiation
Gordon
 
A
Regulation of Hematopoiesis, vol 1.
1970
161
Appleton-Century-Crofts
New York, NY
34
Dexter
 
TM
Allen
 
TD
Lajtha
 
LG
Conditions controlling the proliferation of haemopoietic stem cells in vitro.
J Cell Physiol
91
1977
335
35
Greenberger
 
JS
The hematopoietic microenvironment.
Crit Rev Oncol Hematol
11
1991
65
36
Torok-Storb
 
B
Cellular interactions.
Blood
72
1988
373
37
Gordon
 
MY
Riley
 
GP
Watt
 
SM
Greaves
 
MF
Compartmentalization of a haematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment.
Nature
326
1987
403
38
Roberts
 
RA
Gallagher
 
J
Spooncer
 
E
Allen
 
TD
Bloomfield
 
F
Dexter
 
TM
Heparan sulfate bound growth factors: A mechnism for stromal cell mediated haemopoiesis.
Nature
332
1988
376
39
Dzierzak
 
EA
Medvinsky
 
AL
Mouse embryonic hematopoiesis.
Trends Genet
11
1995
356
40
Van de Run
 
M
Heimfeld
 
S
Spangrude
 
GJ
Weissman
 
IL
Mouse hematopoietic stem-cell antigen Sca-1 is a member of the Ly-6 antigen family.
Proc Natl Acad Sci USA
86
1989
4634
41
Satoh
 
M
Mioh
 
H
Shiotsu
 
Y
Ogawa
 
Y
Tamaoki
 
T
Mouse bone marrow stromal cell line MC3T3-G2/PA6 with hematopoietic-supporting activity expresses high levels of stem cell antigen Sca-1.
Exp Hematol
24
1996
1312
42
Nishi
 
N
Ishikawa
 
R
Inoue
 
H
Nishikawa
 
M
Kakeda
 
M
Yoneya
 
T
Tsumura
 
H
Ohashi
 
H
Yamaguchi
 
Y
Motoki
 
K
Sudo
 
T
Mori
 
KJ
Granulocyte-colony stimulating factor and stem cell factor are the crucial factors in long-term culture of human primitive hematopoietic cells supported by a murine stromal cell line.
Exp Hematol
24
1996
1312
43
Lamy
 
I
Corlu
 
A
Fardel
 
O
Gandemer
 
V
Rialland
 
M
Leberre
 
C
Prise
 
PY
Fauchet
 
R
Coulombel
 
L
Guguen-Guillouzo
 
C
Rat liver biliary epithelial cells support long-term production of heamopoietic progenitors from human CD34+ cells.
Br J Haematol
98
1997
560
44
Kobari
 
L
Bubart
 
A
Pesteur
 
FL
Vainchenker
 
W
Sainteny
 
F
Hematopoietic-promoting activity of the murine stromal cell line MS-5 is not related to the expression of the major hematopoietic cytokines.
J Cell Physiol
163
1995
295
45
Kodama
 
M
Nose
 
M
Niida
 
S
Yamasaki
 
A
Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells.
J Exp Med
173
1991
1291
46
Nakano
 
T
kodama
 
H
Honjo
 
T
Generation of lymphohematopoietic cells from embryonic stem cells in culture.
Science
265
1994
1098
47
Tsuji
 
K
Zsebo
 
KM
Ogawa
 
M
Enhancement of murine blast cell colony formation in culture by recombinant rat stem cell factor, ligand for c-kit.
Blood
78
1991
1223
48
Mukouyama
 
Y
Hara
 
T
Xu
 
MJ
Tamura
 
K
Donovan
 
PJ
Kim
 
HJ
Kogo
 
H
Tsuji
 
K
Nakahata
 
T
Miyajima
 
A
In vitro expansion of murine multipotential hematopoietic progenitors from the embryonic Aorta-Gonad-Mesonephros region.
Immunity
8
1998
105
49
Ichihara
 
M
Hara
 
T
Kim
 
H
Murate
 
T
Miyajima
 
A
Oncostatin M and Leukemia inhibitory factor do not use the same functional receptor in mice.
Blood
90
1997
165
Sign in via your Institution